Sanofi and IGM Biosciences Report Collaboration Agreement for Oncology, Immunology and Inflammation Targets
Sanofi (NASDAQ: SNY) and IGM Biosciences, Inc. (NASDAQ: IGMS) has reported signature of an exclusive worldwide collaboration agreement to create, develop, manufacture and commercialize IgM antibody agonists against three oncology targets and three immunology/inflammation targets. “We look forward to this...